Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00316056 · ClinicalTrials.gov registry record
Use of Virtual Reality to Communicate Concepts of Genomics to the General Public
A clinical trial of Healthy and Communication, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 346
- Enrollment target
- 1
- Study location
NCT00316056: Completed study of Healthy and Communication, sponsored by National Human Genome Research Institute (NHGRI).
NCT00316056 is a study of Healthy and Communication that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 346 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00316056, a study of Healthy and Communication, has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 346 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate how people learn best about genetics. It involves participating in activities in NHGRI's Immersive Virtual Environment Laboratory (IVE lab), where digital "virtual worlds" are created that appear to surround the subject when he or she wears a head-mounted display. English-speaking men and women between 18 and 40 years of age may be eligible for this study. Participants are randomly assigned to one of two groups, each of which receives a different type of information, once in the IVE lab. Subjects complete a questionnaire before and after performing the activities in the lab. The questionnaire evaluates the subject's knowledge of genetics and tests some reading and number skills. ...
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 346 participants |
| Start Date | 2006-04-14 |
What the finished NCT00316056 record still lists
NCT00316056 is an observational study that tracks outcomes without assigning an intervention. The registered 346 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (47% lower).
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 0 interventions.
NCT00316056 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00316056 about?
NCT00316056 is a clinical study titled "Use of Virtual Reality to Communicate Concepts of Genomics to the General Public". This study will investigate how people learn best about genetics. It involves participating in activities in NHGRI's Immersive Virtual Environment Laboratory (IVE lab), where digital "virtual worlds" are created that appear to surround the subject when he or she wears a head-mounted display. Englis...
What is the current status of trial NCT00316056?
This trial is currently completed. The enrollment target is 346 participants. The study started on 2006-04-14.
What conditions does trial NCT00316056 study?
This clinical trial studies the following conditions: Healthy, Communication, Learning.
Who is sponsoring clinical trial NCT00316056?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00316056 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00316056's enrollment target sits among peer trials
346 72nd of 1090 higher than 1,019 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267886 · 346 participants · Phase 4
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
- NCT06705842 · 346 participants · Phase 4
APPI-Cost Trial for Perforated Appendicitis
- NCT06932887 · 346 participants · Phase 3
The Beat Pain Better Trial
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI